ARIPLY 5 – Aripiprazole

    Formulation :

    Tablets

    Composition :

    Each tablet contains 5 mg Aripiprazole and also contains 26 mg lactose.

    Indications :

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Dosage :

    Ariply 5 mg

    Ariply 10 mg

    Ariply 15 mg

    Ariply 30 mg

    Packing :

    Each package contains 28 tablets.


ARIPLY 5 – Aripiprazole

For treatment of schizophrenia.
For treatment of moderate to severe manic states in bipolar disorder type 1
and for the prevention of new manic episodes in patients who predominantly
experienced manic episodes and who had previous manic episodes that responded
to aripiprazole treatment.
In addition, Ariply 5, 10, 15 are intended:
For combined treatment in major depressive disorder (MDD) for patients who
experienced a partial response to therapy.
For treatment of restlessness associated with an autistic disorder in children
(ages 6-17).